MS Patients Choose Death Risk With Potent Drug Treatment

MS Patients Choose Death Risk With Potent Drug Treatment

Biogen Idec Inc. via Bloomberg

Tysabri is the most effective multiple sclerosis medicine available, generating $1.1 billion annually for Weston, Massachusetts-based Biogen Idec Inc.